OUTCOME OF MECHANICAL VENTILATION FOR ADULTS WITH HEMATOLOGIC MALIGNANCY

Citation
De. Epner et al., OUTCOME OF MECHANICAL VENTILATION FOR ADULTS WITH HEMATOLOGIC MALIGNANCY, Journal of investigative medicine, 44(5), 1996, pp. 254-260
Citations number
39
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
ISSN journal
10815589
Volume
44
Issue
5
Year of publication
1996
Pages
254 - 260
Database
ISI
SICI code
1081-5589(1996)44:5<254:OOMVFA>2.0.ZU;2-H
Abstract
Background: Patients with hematologic malignancy who develop respirato ry failure generally have a very poor prognosis, A few such patients, however, enjoy long-term survival, The objective of this study was to identify clinical characteristics of patients with hematologic maligna ncy and respiratory failure that are predictive of outcome, Methods: W e performed a retrospective chart review of all patients who required mechanical ventilation for acute respiratory failure while on the leuk emia or bone marrow transplantation units at the Johns Hopkins Oncolog y Center between January 1985 and October 1991 (n = 157), Results: Ove rall hospital mortality was 83%, Major organ system dysfunction, as me asured by the acute physiology score (APS) of the APACHE III prognosti c system, was significantly (P < 0.05) related to hospital mortality, Three disease-specific clinical characteristics were predictive of mor tality: 1) stage beyond first complete remission, 2) duration of neutr openia greater than 30 days, and 3) treatment with bone marrow transpl antation, especially if HLA-mismatched, None of the 15 (10%) patients with neutropenia greater than 30 days or the four patients who underwe nt HLA-mismatched transplantation survived to discharge, Age was also a significant predictor of hospital mortality, Conclusions: Overall ou tcome of patients with hematologic malignancy and acute respiratory fa ilure is poor, A larger prospective study will be required to confirm the relative value of disease-specific variables identified in this st udy when combined with established predictive variables, In the future , it may be possible to develop a predictive instrument that is specif ically tailored for patients with hematologic malignancy who develop r espiratory failure.